PanTera aims to secure the large-scale production of actinium-225 (225Ac), one of the most promising alpha-emitting radioisotopes to fight cancers by Targeted RadioTherapy (TRT). By working towards this large-scale production, PanTera’s ultimate goal is to improve the accessibility of future innovative cancer therapy based on 225Ac and theranostics in general.
| Website | https://www.pantera-life.com |
| Employees | 63 (22 on RocketReach) |
| Founded | 2022 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Radioisotope Production, Radiopharmaceutical Manufacturing, Nuclear Medicine, Isotope Separation, Nuclear Medicine Technology, Cancer Treatment, Radioactive Materials, Medical Isotopes, Radiotherapy, Pharmaceutical Manufacturing, Cancer Therapy, Drug Development, Oncology, Clinical Trials |
| Competitors | Trulieve, Curaleaf, Cresco Labs, Green Thumb Industries (GTI), Tilray Brands, Inc., Canopy Growth Corporation, MedMen, Aphria, Hexo, Harvest HOC +31 more (view full list) |
Looking for a particular PANTERA employee's phone or email?
Sven van Den Berghe is the CEO of PANTERA.
22 people are employed at PANTERA.